argenx SE | ARGX - Cost Of Sales

Stock Price
695.60
Daily Change
-20.40 -2.85%
Monthly
-1.08%
Yearly
10.06%
Q1 Forecast
686.63

argenx SE reported $109.43M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AstraZeneca USD 2.8B 328M Sep/2025
Galapagos EUR 84.73M 80.02M Sep/2025
Genmab DKK 57M 15M Jun/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Qiagen NV USD 187.78M 11.47M Sep/2025
UCB EUR 901M 50M Dec/2024